STRUCTURE,STRUCTURE_ID,STRUCTURE_NAME,ACTION,REF_AREA,Reference area,MEASURE,Measure,UNIT_MEASURE,Unit of measure,MARKET_TYPE,Market type,PHARMACEUTICAL,Pharmaceutical,TIME_PERIOD,Time period,OBS_VALUE,Observation value,OBS_STATUS,Observation status,OBS_STATUS2,Observation status 2,OBS_STATUS3,Observation status 3,UNIT_MULT,Unit multiplier,DECIMALS,Decimals
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,83.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,56.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,86.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,58.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,92.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,60.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,98.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,59.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,102.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,57.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,1.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,38.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,38.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,2.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,39,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,39.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,39.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,39.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,1.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,40.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,41.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,42.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,43.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,44.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,45.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,47.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,9.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,13.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,14,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,10.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,11.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,14,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,14.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,12.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,13.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,15,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,15.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,15,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,16.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,15,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,15.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,17.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,19.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,16.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,16,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,21.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,24.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,15.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,16.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,26.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,28.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LVA,Latvia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,16.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,11.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,13.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,15.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,14.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,14.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,17,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,18,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,13.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,13.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,20.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,11.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,18.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,21,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,12.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,12.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,23.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,27.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,14,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,14.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,31.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,34.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,14.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,14.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,37,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,11.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,25.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,42.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,12.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,10.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,41.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,43.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,11.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,11.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,46.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,36.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,10.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,8.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,42,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,40.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,8.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,5.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,52,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,67,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,7.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,90.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,94.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,4.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,5.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,95.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,104,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CHL,Chile,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,5.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,36.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,19.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,20.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,37.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,40.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,23.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,24.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,41.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,41.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,25.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,27.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,41,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,40.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,29.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,32.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,37.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,33.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,31.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,35.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,32.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,29.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,36.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,37.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,25,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,22.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,40.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,42.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LTU,Lithuania,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,22.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,21.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,9.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,8.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,24.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,26.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,8.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,9.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,29.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,29.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,9.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,8.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,28.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,29.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,8.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,8.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,30.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,33.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,8.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,9.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,35.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,39,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,9.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,9.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,41.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,34.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,10.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CRI,Costa Rica,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,47.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,2.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,32.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,37,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,2.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,37.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,36.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,38.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,40.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,2.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,41,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,43.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,1.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,1.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,44.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,44.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,2.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,48.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,52.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,2.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,2.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,55.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,60.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,TUR,Türkiye,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,2.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,51.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,51,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,52,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,50.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,51.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,49.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,51.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,49.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,51.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,47.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,51.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,46.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,51.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,45.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,51.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,44.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,54.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,42.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,54.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,42.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,57.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,47,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,61.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,46.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,63.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,40.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,23.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,63.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,65.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,24.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,25.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,68.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,71.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,26.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,27.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,72.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,74.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,27.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,29.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,76.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,75.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,30.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,32.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,78.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,79.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,33.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,35.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,81,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,83.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,37.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,38.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,82.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,79.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HRV,Croatia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,39.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,47,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,18.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,18.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,50,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,51,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,17.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,17.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,53.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,55,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,16.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,15.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,56.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,58.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,14.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,13.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,59.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,61.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,13,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,12.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,63.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,63.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,12,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,11.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,66.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,68.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,11.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,10.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVN,Slovenia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,70.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,101.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,24.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,29,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,22.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,22.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,30.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,30.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,21.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,24,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,35.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,38.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,25.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,24.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,40,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,21.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,39.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,41.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,22.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,23.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,42.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,42.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,24.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,25.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,44.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,47.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,24.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,23.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,49.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,13.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,15.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,17.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,13.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,14,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,20.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,21.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,14.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,14.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,23.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,24.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,14.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,14,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,27.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,28.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,13.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,12.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,31.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,34.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,13,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,13.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,37,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,40.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,13,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,13.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,44.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,47.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,11.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,10.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,EST,Estonia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,52.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,16.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,75.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,79.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,16.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,15.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,81.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,84.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,15.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,15,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,87.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,92.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,14.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,13.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,95,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,96.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,12.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,11.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,98.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,102.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,11.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,10.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,105.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,108.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,10,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,9.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,114.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,117.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,9.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,8.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SWE,Sweden,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,121.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,19.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,56.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,57.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,18.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,17.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,57.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,56.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,16.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,16,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,57.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,58,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,14.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,14,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,57.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,57.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,13.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,12.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,56.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,57.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,12,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,12,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,58.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,61.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,11.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,11.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,63.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,63.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,11.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,10.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NOR,Norway,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,65.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,11.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,84,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,85.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,10.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,10.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,83.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,80,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,9.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,76.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,77,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,8.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,7.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,76.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,75.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,6.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,6.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,76.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,78.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,5.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,5.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,80.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,84.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,4.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,4.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,88.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,92.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,4.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DNK,Denmark,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,96.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,27.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,69.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,70.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,26.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,25.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,69.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,69.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,24.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,23,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,68.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,68.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,21.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,20,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,67.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,70.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,18.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,17.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,74.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,78.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,16.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,15.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,81.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,85.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,14.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,14.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,88.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,92.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,13.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,12.8,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FIN,Finland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,97.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,41.6,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,15.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,44.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,14.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,46.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,13.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,49,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,12.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,52.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,12.5,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,55,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,12.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,57.1,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,12,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,59.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,11.9,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,61.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,11.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,64.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,11.2,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,65.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,11,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,69.4,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,10.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,73.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,10.7,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,75.3,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CZE,Czechia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,10,,,,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,4.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,46.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,4.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,50,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,4.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,51.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,4.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,53.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,55.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,3.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,56.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,3.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,56.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,3.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,56.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,3.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,60.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,3.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,62.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,3.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,64,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,65.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,2.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,66.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,80.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,15.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,15.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,88.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,91.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,13.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,100.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,10.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,9.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,104.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,106.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,9.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,8.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,109.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,112.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,7.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,7.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,115.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,122.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,6.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,6.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,127.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,130.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,5.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,68.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,70,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,70.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,72.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,74.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,77.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,79,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,78.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,79.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,81.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,83.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,86.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,88.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,BEL,Belgium,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,90.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,26.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,24.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,26.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,27.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,26.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,26.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,28.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,27.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,27.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,28.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,28.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,28.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,28.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,27.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,27.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,28.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,29.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,26.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,25.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,29.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,30.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,25.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,23.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,29.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,30.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,22.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,22.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,30.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,31.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,HUN,Hungary,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,21.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,93.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,79.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,93,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,78.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,96.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,84.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,97.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,87.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,97,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,91.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,96.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,94.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,94.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,99,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,93.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,103.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,91.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,108.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,88.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,122.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,83.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,129.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,85.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,137.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,83.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,148.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,78.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,151.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,6.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,40.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,6.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,41.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,6.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,42.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,6.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,43.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,6.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,44.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,6.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,45.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,46.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,7.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,46.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,47.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,7.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,7.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,48,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,48.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,7.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,6.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,48.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,49.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,6.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,6.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NLD,Netherlands,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,50.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,41.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,50.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,51.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,40.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,38.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,52,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,53.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,36.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,36.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,56,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,54.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,35.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,34.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,55,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,54.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,33,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,31.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,54,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,54.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,30.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,30.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,55.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,27.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,58.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,61.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,51.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,63.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,52,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,64,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,51.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,65.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,52.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,73.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,56.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,75.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,56.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,77.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,56.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,54.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,7.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,57.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,58.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,7.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,59.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,8.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,60.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,8.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,60.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,60.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,7.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,61,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,7.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,61.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,7.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,62,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,7.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,63.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,6.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,63.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,6.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,63.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,61.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUT,Austria,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,6.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,12.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,78.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,82.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,12.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,12,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,83.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,85,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,11.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,87.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,10.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,90.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,10,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,104.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,9.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,108.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,8.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,114.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,7.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,122,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,7.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,130.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,6.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,134,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,6.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,133.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,5.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,99,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,22.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,105.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,22,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,108.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,21.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,119.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,21.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,125.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,21.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,133.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,20.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,137.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,19.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,142,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,18.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,151.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,19.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,165.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,19.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,162.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,18.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,19,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,168.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,168.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,18.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,7.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,34.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,42.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,7.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,7.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,44.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,46.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,7.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,7.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,49.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,51.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,7.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,7.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,53.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,55.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,7.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,57.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,61.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,65.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,69.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISR,Israel,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,5.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,65.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,70.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2012,,4.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2012,,75,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,5.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,87.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,94.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,5.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,5.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,100.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,107.9,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,44.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,22.7,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2015,,23.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2015,,48.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2017,,25.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2017,,55.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,58,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,25.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,27.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,61,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,65.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,32.4,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,32.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,70.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,73.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,32.1,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,32,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,76.5,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,80.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,31.8,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,24.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,0.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,0.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,27.3,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,30.6,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,0.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,0.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,35.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,39.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,0.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,0.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,POL,Poland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,44.2,,D,Definition differs,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2010,,53.4,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,FRA,France,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2010,,53,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,14.9,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,13.8,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,17.2,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,KOR,Korea,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,12.4,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,38.9,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,SVK,Slovak Republic,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,22.1,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,80.4,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,56.8,,B,Time series break,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,81.4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,3.9,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,82.6,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,81.4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,92,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,96,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,3.9,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,100.4,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,48.5,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ITA,Italy,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,2.1,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,100.6,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,NZL,New Zealand,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,3.8,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PER,Peru,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,4.2,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PER,Peru,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,8.1,,E,Estimated value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,75.5,,P,Provisional value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,PRT,Portugal,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,163.4,,P,Provisional value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,106.1,,P,Provisional value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,55.4,,P,Provisional value,,,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,5,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,116.5,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2019,,123.9,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2019,,4.8,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2020,,4.7,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2020,,131.7,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,138.2,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,4.5,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2022,,3.7,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2022,,135.6,,E,Estimated value,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,21.7,,D,Definition differs,P,Provisional value,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,56.8,,D,Definition differs,P,Provisional value,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,60.1,,D,Definition differs,P,Provisional value,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,26.3,,D,Definition differs,P,Provisional value,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2024,,134.6,,D,Definition differs,P,Provisional value,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2024,,5.5,,D,Definition differs,P,Provisional value,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2018,,3.4,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,DEU,Germany,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2018,,58.5,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2016,,100.1,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,CAN,Canada,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2016,,10.3,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2011,,95.9,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ISL,Iceland,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2011,,23.3,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2021,,57.3,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,LUX,Luxembourg,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2021,,28.6,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2014,,71.3,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,ESP,Spain,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2014,,56.4,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2023,,136.9,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2023,,3.5,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,11.4,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,AUS,Australia,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,96.2,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,23.4,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GRC,Greece,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,44.7,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N06A,Antidepressants,2013,,82.3,,B,Time series break,D,Definition differs,,,0,Units,,
DATAFLOW,OECD.ELS.HD:HEALTH_PHMC@DF_KEY_INDIC(1.1),Pharmaceutical market,I,GBR,United Kingdom,PH_CON,Pharmaceutical consumption,DDD_10P3HB,Defined daily dose per 1 000 inhabitants per day,_Z,Not applicable,N05B,Anxiolytics,2013,,5.8,,B,Time series break,D,Definition differs,,,0,Units,,
